Gartner® Report – Predicts 2024: Generative AI Brings New Value to Life Sciences
GenAI is broader than traditional computer systems, which typically function by making operational decisions based on predetermined criteria already anticipated and comprehensively tested. Many life science companies are investigating this technology for content and insight generation, with the promise of process optimization driving adoption.
This Gartner report aligns with what Benchling has also heard from customers: in order to succeed with AI, biotechs need to increase data quality in order to improve the chances of R&D success while massively reducing the timeline to these breakthroughs.
The life science industry is experiencing a generative AI (GenAI) boom and increasing availability of AI-native vendors
Machine learning algorithms are ever increasing in complexity, and outputs are still difficult to explain
Life science organizations are embracing virtual assistants (VAs) to address the need for efficiency in a competitive market
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
View Gartner report
Join over 200,000 scientists using Benchling to power their biotech R&D
